Tags

Type your tag names separated by a space and hit enter

Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
Hepatology 2014; 60(4):1399-408Hep

Abstract

The Drug-Induced Liver Injury Network (DILIN) studies hepatotoxicity caused by conventional medications as well as herbals and dietary supplements (HDS). To characterize hepatotoxicity and its outcomes from HDS versus medications, patients with hepatotoxicity attributed to medications or HDS were enrolled prospectively between 2004 and 2013. The study took place among eight U.S. referral centers that are part of the DILIN. Consecutive patients with liver injury referred to a DILIN center were eligible. The final sample comprised 130 (15.5%) of all subjects enrolled (839) who were judged to have experienced liver injury caused by HDS. Hepatotoxicity caused by HDS was evaluated by expert opinion. Demographic and clinical characteristics and outcome assessments, including death and liver transplantation (LT), were ascertained. Cases were stratified and compared according to the type of agent implicated in liver injury; 45 had injury caused by bodybuilding HDS, 85 by nonbodybuilding HDS, and 709 by medications. Liver injury caused by HDS increased from 7% to 20% (P < 0.001) during the study period. Bodybuilding HDS caused prolonged jaundice (median, 91 days) in young men, but did not result in any fatalities or LT. The remaining HDS cases presented as hepatocellular injury, predominantly in middle-aged women, and, more frequently, led to death or transplantation, compared to injury from medications (13% vs. 3%; P < 0.05).

CONCLUSIONS

The proportion of liver injury cases attributed to HDS in DILIN has increased significantly. Liver injury from nonbodybuilding HDS is more severe than from bodybuilding HDS or medications, as evidenced by differences in unfavorable outcomes (death and transplantation). (Hepatology 2014;60:1399-1408).

Authors+Show Affiliations

Hepatology Division, Department of Medicine, Einstein Medical Center, Philadelphia, PA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

25043597

Citation

Navarro, Victor J., et al. "Liver Injury From Herbals and Dietary Supplements in the U.S. Drug-Induced Liver Injury Network." Hepatology (Baltimore, Md.), vol. 60, no. 4, 2014, pp. 1399-408.
Navarro VJ, Barnhart H, Bonkovsky HL, et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 2014;60(4):1399-408.
Navarro, V. J., Barnhart, H., Bonkovsky, H. L., Davern, T., Fontana, R. J., Grant, L., ... Vuppalanchi, R. (2014). Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology (Baltimore, Md.), 60(4), pp. 1399-408. doi:10.1002/hep.27317.
Navarro VJ, et al. Liver Injury From Herbals and Dietary Supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 2014;60(4):1399-408. PubMed PMID: 25043597.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. AU - Navarro,Victor J, AU - Barnhart,Huiman, AU - Bonkovsky,Herbert L, AU - Davern,Timothy, AU - Fontana,Robert J, AU - Grant,Lafaine, AU - Reddy,K Rajender, AU - Seeff,Leonard B, AU - Serrano,Jose, AU - Sherker,Averell H, AU - Stolz,Andrew, AU - Talwalkar,Jayant, AU - Vega,Maricruz, AU - Vuppalanchi,Raj, Y1 - 2014/08/25/ PY - 2014/03/13/received PY - 2014/07/10/accepted PY - 2014/7/22/entrez PY - 2014/7/22/pubmed PY - 2015/5/12/medline SP - 1399 EP - 408 JF - Hepatology (Baltimore, Md.) JO - Hepatology VL - 60 IS - 4 N2 - UNLABELLED: The Drug-Induced Liver Injury Network (DILIN) studies hepatotoxicity caused by conventional medications as well as herbals and dietary supplements (HDS). To characterize hepatotoxicity and its outcomes from HDS versus medications, patients with hepatotoxicity attributed to medications or HDS were enrolled prospectively between 2004 and 2013. The study took place among eight U.S. referral centers that are part of the DILIN. Consecutive patients with liver injury referred to a DILIN center were eligible. The final sample comprised 130 (15.5%) of all subjects enrolled (839) who were judged to have experienced liver injury caused by HDS. Hepatotoxicity caused by HDS was evaluated by expert opinion. Demographic and clinical characteristics and outcome assessments, including death and liver transplantation (LT), were ascertained. Cases were stratified and compared according to the type of agent implicated in liver injury; 45 had injury caused by bodybuilding HDS, 85 by nonbodybuilding HDS, and 709 by medications. Liver injury caused by HDS increased from 7% to 20% (P < 0.001) during the study period. Bodybuilding HDS caused prolonged jaundice (median, 91 days) in young men, but did not result in any fatalities or LT. The remaining HDS cases presented as hepatocellular injury, predominantly in middle-aged women, and, more frequently, led to death or transplantation, compared to injury from medications (13% vs. 3%; P < 0.05). CONCLUSIONS: The proportion of liver injury cases attributed to HDS in DILIN has increased significantly. Liver injury from nonbodybuilding HDS is more severe than from bodybuilding HDS or medications, as evidenced by differences in unfavorable outcomes (death and transplantation). (Hepatology 2014;60:1399-1408). SN - 1527-3350 UR - https://www.unboundmedicine.com/medline/citation/25043597/full_citation L2 - https://doi.org/10.1002/hep.27317 DB - PRIME DP - Unbound Medicine ER -